A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting 50 enrolled Fudan University

NaSingle-groupOpen-labelTreatment

Summary

To explore the safety, tolerability, initial efficacy, pharmacokinetic profile and radiation dosimetry of lutetium \[177Lu\]-FAP-75 in the treatment of patients with advanced solid tumors.

Timeline

Start: 2024-08-19
Primary completion: 2025-02-18
Completion: 2025-08-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lutetium [177Lu]-FAP-75	Unknown	—	—

A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Summary

Timeline

Drugs

Indications